VTEX VTEX 深 滬
已收盤 08-01 16:00:00 美东时间
5.79
-0.180
-3.02%
華盛通- 最 高5.915
- 今 開5.82
- 成交量 78.04万股
- 最 低 5.785
- 昨 收 5.97
- 總市值 10.54亿
- 52周最高 8.0298
- 市盈率 靜 92.79
- 換手率 0.43%
- 52周最低 4.195
- 委 比 -72.79%
- 總股本 1.82亿
- 歷史最高 33.36
- 量 比 1.19
- 振 幅 2.18%
- 歷史最低 2.66
- 每 手 1
- 風險率 0.76%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 买入！Darden Restaurants获多家大行上调目标价；瑞银维持特斯拉"卖出"评级，目标价升至215美元
买入！Darden Restaurants获多家大行上调目标价；瑞银维持特斯拉"卖出"评级，目标价升至215美元>>
06-24 10:07
Citigroup Initiates Coverage On Vtex with Buy Rating, Announces Price Target of $10
Citigroup analyst Leandro Bastos initiates coverage on Vtex (NYSE:VTEX) with a Buy rating and announces Price Target of $10.
06-23 20:39
美股大行评级 | 潜在涨幅290.69%！乌龙制药获丰业银行升目标价至47美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1140565699993591809.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 丰业银行：维持乌龙制药(URGN)"跑赢大市"评级，目标价从23美元升至47美元</p> <p>• Guggenheim：维持ADC Therapeutics(ADCT)"买入"评级，目标价从7美元升至10美元</p>
06-16 08:40
UBS Maintains Buy on Vtex, Lowers Price Target to $10
UBS analyst Leonardo Olmos maintains Vtex (NYSE:VTEX) with a Buy and lowers the price target from $11 to $10.
06-13 21:16
美股大行评级 | 高盛上调微软目标价从480美元至550美元，Snowflake获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1132593314765758464.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持IDEAYA Biosciences(IDYA)"超配"评级，目标价从63美元升至66美元</p> <p>• Needham：上调Inogen(INGN)评级至"买入"，目标价12美元</p> <p>• E
05-23 11:19
Jefferies Initiates Coverage On Vtex with Hold Rating, Announces Price Target of $7.3
Jefferies analyst Antonio Pedro Cardoso initiates coverage on Vtex (NYSE:VTEX) with a Hold rating and announces Price Target of $7.3.
05-22 19:16
Vtex shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance.
Vtex shares are trading higher after the company reported better-than-expected ...
05-07 23:56
美股大行评级 | 潜在涨幅684.71%！Verve Therapeutics获Canaccord Genuity升目标价至39美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1119185980869894144.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Canaccord Genuity：维持Verve Therapeutics(VERV)"买入"评级，目标价从32美元升至39美元</p> <p>• HC Wainwright & Co.：维持Verve Ther
04-16 09:45
VTEX Announces Transition to US GAAP for Enhanced Financial Transparency
An announcement from VTEX ( ($VTEX) ) is now available. On April 15, 2025, VTEX...
04-16 04:28
VTEX Announces 2025 AGM and Transition to U.S. GAAP
VTEX ( ($VTEX) ) has provided an announcement. VTEX has announced its upcoming ...
03-27 04:29
